These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 2569034

  • 21. Comparison of different agonists and antagonists of luteinizing hormone-releasing hormone for receptor-binding ability to rat pituitary and human breast cancer membranes.
    Fekete M, Bajusz S, Groot K, Csernus VJ, Schally AV.
    Endocrinology; 1989 Feb; 124(2):946-55. PubMed ID: 2536323
    [Abstract] [Full Text] [Related]

  • 22. Regulation of luteinizing hormone-releasing hormone receptor binding by heterologous and autologous receptor-stimulated tyrosine phosphorylation.
    Liebow C, Lee MT, Kamer AR, Schally AV.
    Proc Natl Acad Sci U S A; 1991 Mar 15; 88(6):2244-8. PubMed ID: 1672452
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of the growth of some hormone dependent tumors by D-Trp6-LH-RH.
    Schally AV, Redding TW, Comaru-Schally AM.
    Med Oncol Tumor Pharmacother; 1984 Mar 15; 1(2):109-18. PubMed ID: 6242477
    [Abstract] [Full Text] [Related]

  • 24. Synthesis and biological activity of [D-Trp6] chicken luteinizing hormone-releasing hormone.
    Millar RP, King JA.
    Peptides; 1983 Mar 15; 4(4):425-9. PubMed ID: 6316292
    [Abstract] [Full Text] [Related]

  • 25. Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.
    Radulovic S, Comaru-Schally AM, Milovanovic S, Schally AV.
    Pancreas; 1993 Jan 15; 8(1):88-97. PubMed ID: 8093555
    [Abstract] [Full Text] [Related]

  • 26. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines.
    Emons G, Ortmann O, Becker M, Irmer G, Springer B, Laun R, Hölzel F, Schulz KD, Schally AV.
    Cancer Res; 1993 Nov 15; 53(22):5439-46. PubMed ID: 8221683
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH.
    Yano T, Korkut E, Pinski J, Szepeshazi K, Milovanovic S, Groot K, Clarke R, Comaru-Schally AM, Schally AV.
    Breast Cancer Res Treat; 1992 Nov 15; 21(1):35-45. PubMed ID: 1391973
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.
    Redding TW, Schally AV.
    Proc Natl Acad Sci U S A; 1981 Oct 15; 78(10):6509-12. PubMed ID: 6458815
    [Abstract] [Full Text] [Related]

  • 29. Combination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model.
    Schally AV, Kook AI, Monje E, Redding TW, Paz-Bouza JI.
    Proc Natl Acad Sci U S A; 1986 Nov 15; 83(22):8764-8. PubMed ID: 2946045
    [Abstract] [Full Text] [Related]

  • 30. Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells.
    Segal-Abramson T, Kitroser H, Levy J, Schally AV, Sharoni Y.
    Proc Natl Acad Sci U S A; 1992 Mar 15; 89(6):2336-9. PubMed ID: 1312718
    [Abstract] [Full Text] [Related]

  • 31. Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.
    Srkalovic G, Bokser L, Radulovic S, Korkut E, Schally AV.
    Endocrinology; 1990 Dec 15; 127(6):3052-60. PubMed ID: 2174343
    [Abstract] [Full Text] [Related]

  • 32. Radioimmunoassay for 6-D-tryptophan analog of luteinizing hormone-releasing hormone: measurement of serum levels after administration of long-acting microcapsule formulations.
    Mason-Garcia M, Vigh S, Comaru-Schally AM, Redding TW, Somogyvari-Vigh A, Horvath J, Schally AV.
    Proc Natl Acad Sci U S A; 1985 Mar 15; 82(5):1547-51. PubMed ID: 3156381
    [Abstract] [Full Text] [Related]

  • 33. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines.
    Emons G, Schröder B, Ortmann O, Westphalen S, Schulz KD, Schally AV.
    J Clin Endocrinol Metab; 1993 Dec 15; 77(6):1458-64. PubMed ID: 8263128
    [Abstract] [Full Text] [Related]

  • 34. Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207.
    Chatzistamou L, Schally AV, Nagy A, Armatis P, Szepeshazi K, Halmos G.
    Clin Cancer Res; 2000 Oct 15; 6(10):4158-65. PubMed ID: 11051271
    [Abstract] [Full Text] [Related]

  • 35. Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice.
    Redding TW, Schally AV, Radulovic S, Milovanovic S, Szepeshazi K, Isaacs JT.
    Cancer Res; 1992 May 01; 52(9):2538-44. PubMed ID: 1568223
    [Abstract] [Full Text] [Related]

  • 36. Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists.
    Szende B, Srkalovic G, Groot K, Lapis K, Schally AV.
    Cancer Res; 1990 Jun 15; 50(12):3716-21. PubMed ID: 2160323
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of growth of a prolactin and growth hormone-secreting pituitary tumor in rats by D-tryptophan-6 analog of luteinizing hormone-releasing hormone.
    Torres-Aleman I, Redding TW, Schally AV.
    Proc Natl Acad Sci U S A; 1985 Feb 15; 82(4):1252-6. PubMed ID: 2858096
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of growth of a prolactin-secreting pituitary tumor in rats by analogs of luteinizing hormone-releasing hormone and somatostatin.
    de Quijada MG, Redding TW, Coy DH, Torres-Aleman I, Schally AV.
    Proc Natl Acad Sci U S A; 1983 Jun 15; 80(11):3485-8. PubMed ID: 6134284
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.
    Yano T, Pinski J, Halmos G, Szepeshazi K, Groot K, Schally AV.
    Proc Natl Acad Sci U S A; 1994 Jul 19; 91(15):7090-4. PubMed ID: 7518926
    [Abstract] [Full Text] [Related]

  • 40. Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75.
    Szende B, Srkalovic G, Groot K, Lapis K, Schally AV.
    J Natl Cancer Inst; 1990 Mar 21; 82(6):513-7. PubMed ID: 2156080
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.